Finance

Beta
Lists
HCWB:NASDAQ
Hcw Biologics Inc
$1.33
-7.99%
(-0.12) 1D
Jun 9, 9:58:25 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HCWB...
Open
$1.39
High
$1.41
Low
$1.30
Mkt. cap
9.60M
Avg. vol.
25.78M
Volume
206.65K
52-wk high
$7.35
52-wk low
$0.25
EPS
-$9.45
Beta
2.21
Shares outstanding
6.73M
No. of employees
35
Open
$1.39
High
$1.41
Low
$1.30
Mkt. cap
9.60M
Avg. vol.
25.78M
Volume
206.65K
52-wk high
$7.35
52-wk low
$0.25
EPS
-$9.45
Beta
2.21
Shares outstanding
6.73M
No. of employees
35
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to HCWB in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for HCWB in the last 3 months.
Highest
Current $1.33
$5.00 (+274.78%)
Average
$5.00 (+274.78%)
Lowest
$5.00 (+274.78%)
News stories
From sources across the web
About Hcw Biologics Inc
CEO-
Employees35
Founded2018
HeadquartersMiramar, Florida, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.55K
15.61K
27.01K
6.54M
Cost of goods sold
5.24K
12.48K
21.61K
11.07K
Cost of revenue
5.24K
12.48K
21.61K
11.07K
Research and development expenses
1.20M
1.38M
1.31M
1.26M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.27M
1.92M
3.66M
2.04M
Operating expense
3.47M
3.30M
4.97M
3.30M
Total operating expenses
3.47M
3.31M
4.99M
3.31M
Operating income
-3.46M
-3.29M
-4.96M
3.24M
Other non operating income
16.37K
-168.86K
-67.86K
676.23K
EBT including unusual items
-1.93M
-4.55M
719.23K
3.80M
EBT excluding unusual items
-3.68M
-3.59M
-5.24M
3.80M
Income tax expense
-
-
-
330.19K
Effective tax rate
-
-
-
8.68%
Other operating expenses
-
-
-
-
Net income
-1.93M
-4.55M
719.23K
3.47M
Net profit margin
-29,430.99%
-29,183.24%
2,662.84%
53.07%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-228.71K
-127.07K
-212.13K
-109.27K
Net interest expenses
-228.71K
-127.07K
-212.13K
-109.27K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.17M
-3.12M
-4.80M
3.38M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more